Wellgistics Health Expands Partnership with Tollo Health to Add Telehealth and AI‑Driven Mental Health Services

WGRX
February 11, 2026

Wellgistics Health, Inc. (NASDAQ:WGRX) announced on February 11 2026 that it is expanding its partnership with Tollo Health, LLC, adding TolloCare’s telehealth services and a new AI‑driven mental‑health application to its EinsteinRx prescription‑management hub and PharmacyChain blockchain platform.

The expansion brings TolloCare’s synchronous and asynchronous telemedicine capabilities—supported by a network of more than 5,000 physicians—into Wellgistics’ AI‑powered workflow. Integration is slated to begin in the first quarter of 2026, with full deployment across the EinsteinRx and PharmacyChain ecosystems expected by the end of 2026.

The mental‑health AI app, developed by a stealth San Francisco Bay Area startup, offers AI‑guided engagement tools for depression, anxiety, and related conditions. It will be embedded within the EinsteinRx portal, allowing pharmacists and independent pharmacy partners to offer patients real‑time mood tracking, cognitive‑behavioral prompts, and secure messaging with licensed clinicians.

Prashant Patel, RPh, President & Interim‑CEO of Wellgistics, said the move “aligns with our strategy to transform from a distribution‑only company into a patient‑centric digital health platform.” The addition of telehealth and AI mental‑health services positions Wellgistics to capture growing demand for remote care and digital therapeutics, a market projected to exceed $200 billion by 2030.

Wellgistics reported a net operating loss of $33.878 million in Q3 2025, reflecting a decline in revenue and ongoing investment in technology. The partnership expansion is intended to create new revenue streams for independent pharmacies, but the company has not yet disclosed specific financial projections for the new services. Investors will be watching for how the added services translate into incremental revenue and margin improvement.

The partnership builds on a February 2025 expansion that saw Wellgistics and Tollo Health market Tollo’s medical foods for GLP‑1 and Long COVID patients. The new telehealth and AI‑mental‑health integration deepens the relationship and expands the scope of services offered to pharmacy partners, marking a significant evolution in Wellgistics’ digital‑health strategy.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.